Reducing medications safely to meet life’s changes
What medications were good then might not be the best choice now. Deprescribing is the planned process of reducing or stopping medications that may no longer be of benefit or may be causing harm. The goal is to reduce medication burden or harm while improving quality of life.
Be part of the change for a better quality of life
Patients
Learn about deprescribing and check out resources to help you discuss deprescribing with your health care provider.
Health Care Providers
Get comfortable deprescribing with tools and resources, case reports and testimonials, and relevant publications.
Researchers
Find out about ongoing research at Bruyère Research Institute and the University of Montreal and join the conversation to share your own research.
As the population ages, older Canadians are living with multiple chronic conditions. In 2016, 35% of community-dwelling seniors had chronic use of 5 or more different drug classes.
Canadian Institute for Health Information. Drug use among seniors 2016.Inappropriate prescriptions are known to pose health risks for older adults, leading to unnecessary hospitalisations and undue cost.
Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. The New England Journal of Medicine. 2011;365(21):2002-12“It is an art of no little importance to administer medicines properly; but it is an art of much greater and more difficult acquisition to know when to suspend or altogether omit them.”
Philippe Pinel 1745-1826What’s happening?
The Unsung Role of the Pharmacist in Patient Health
January 28, 2019 - We know many people end up with a risky pileup of prescribed medications. Many efforts have been made, with varied success, to correct this problem. Yet we’ve usually focused on physician behavior, when there’s another powerful lever: pharmacists....
Acetylcholinesterase inhibitors and memantine deprescribing guideline
Using the evidence-based deprescribing guideline method established through the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, Dr. Reeve developed an Australian/Canadian focused prescribing guideline for acetylcholinesterase inhibitors and...
Building Capacity for Deprescribing Guideline Development, Implementation, and Evaluation
This knowledge mobilization grant supported a variety of strategies designed to help health care providers and members of the public use deprescribing guidelines effectively. These included whiteboard training videos, mobile apps, webinars, a wide-reaching social...
Keep up with the latest
Evolving our understanding about the scope and appropriateness of prescribing cascades is an important step in… twitter.com/i/web/status/1…
New article discusses #deprescribing #benzodiazepines, how nurse practioners can engage patients in deprescribing,… twitter.com/i/web/status/1…
In Australia “most older adults and caregivers are willing to have one of their or their care recipient's medicatio… twitter.com/i/web/status/1…
The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults has been updated by using new evide… twitter.com/i/web/status/1…
Weren’t able to attend last week’s webinar on a Team Approach to #Deprescribing and Preventing Medication Related F… twitter.com/i/web/status/1…
Important thread - consider #deprescribing twitter.com/davidjuurlink/…
Would you like to get involved more?
Are you a patient, a caregiver or a researcher? You can participate in the discussion about deprescription.
Would you like more information?
We are here to help you. If you wish to obtain more information concerning elements found on our site, please contact us.